13:41 IST
BSE
Other Announcement
Sun Pharma Advanced Research Company Other Announcement
Sun Pharma Advanced Research Company Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026.
Sun Pharma Advanced Research Company Ltd
- Share price
- ₹196.73
- Market cap
- ₹6,384 Cr
- Revenue (annual)
- ₹1,879 Cr
- Net profit (annual)
- ₹1,553 Cr
- P/E (TTM)
- 4.0×Sector 47.4×
- Promoter holding
- 65.67%+0.00% QoQ
- FII holding
- 3.90%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 4Management Change 3Financial Results 3Annual General Meeting 3Promoter Reclassification 2Fund Raise 2Business Update 2Board Meeting Date 2Merger & Restructuring 1Annual Report 1Adverse Business Impact 1
Time
4 announcements with these filters
14:56 IST
BSE
Other Announcement
Sun Pharma Advanced Research Company Other Announcement
Sun Pharma Advanced Research Company Limited submitted the Monitoring Agency Report for the quarter ended June 30, 2026. The report confirms zero deviation in utilizing proceeds from its Rs. 599.98 Crore warrant issue.
- Value
- ₹600.0 Cr
14:15 IST
BSE
Other Announcement
Sun Pharma Advanced Research Company Other Announcement
Sun Pharma Advanced Research Company Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026. The filing details equity holdings across promoter and public categories.
16:39 IST
NSE
Other Announcement
Sun Pharma Advanced Research Company Other Announcement
Sun Pharma Advanced Research Company (SPARC) submitted its quarterly compliance certificate for the period ended March 31, 2026. The certificate confirms that securities received for dematerialisation were processed and listed on stock exchanges within prescribed timelines. This is a routine regulatory filing with no material financial impact.